NCT06134375 2026-03-12A Study of Tetrathiomolybdate (TM) Plus CapecitabineDartmouth-Hitchcock Medical CenterPhase 1/2 Recruiting204 enrolled
NCT02767934 2020-08-20Pembrolizumab in Treating Minimal Residual Disease in Patients With Acute Lymphoblastic LeukemiaUniversity of WashingtonPhase 2 Terminated12 enrolled 12 charts